Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year. In recent years, a number of changes have taken place in the area of pharmaceutical legislation. The legal pharmaceutical framework in Romania was fully compliant with that of the EU until the introduction of new EU laws in May 2004. Romanian legislation was harmonised with EU regulations again in 2005. In January 2007, Romania joined the EU, as expected; therefore relevant legislation such as EU trademarks now applies to medicinal products.

Around 90% of the pharmaceutical market is supplied by imports. France, Germany and the UK were the leading suppliers in 2005, accounting for over 40% of the total. Imports grew by 20.2% in 2005 to reach US$1.1 billion.

A number of Romanian pharmaceutical companies were acquired in 2006; the subsequent transfer of technology should improve the overall quality of production and increase the range of products on the market. GMP standards became mandatory in January 2004, but this initially resulted in the closure of around 30 facilities, due to a lack of funding required for modernisation. Although Romanian companies tend to focus on supplying the domestic market, recent acquisitions have allowed the market leaders to tap into new export markets and reach a wider audience; sales have grown rapidly as a result.